BamSEC and AlphaSense Join Forces
Learn More
You must log in to view this page.

NeuroOne Medical Technologies Corporation – Material Contracts

NASDAQ: NMTC    
Share price (6/29/26): $3.34    
Market cap (6/29/26): $28.8 million
Search in Documents
Key Exhibits
External Links

Material Contracts Filter

EX-10.3
from 10-Q 2 pages Second Amendment to Offer Letter
12/34/56
EX-10.2
from 10-Q 1 page Third Amendment to NeuroOne Medical Technologies Corportaion 2021 Inducement Plan
12/34/56
EX-10.1
from 8-K 8 pages Transition and Release Agreement
12/34/56
EX-10.1
from 8-K 1 page First Amendment to NeuroOne Medical Technologies Corporation 2025 Equity Incentive Plan Recitals
12/34/56
EX-10.1
from 10-Q 3 pages First Amendment to Amended and Restated Exclusive Development and Distribution Agreement
12/34/56
EX-10.1
from 10-Q 1 page Second Amendment to NeuroOne Medical Technologies Corportaion 2021 Inducement Plan
12/34/56
EX-10.3
from 8-K/A 8 pages NeuroOne Medical Technologies Corporation Stock Option Grant Notice
12/34/56
EX-10.2
from 8-K/A 6 pages NeuroOne Medical Technologies Corporation Rsu Award Grant Notice
12/34/56
EX-10.1
from 8-K/A 24 pages NeuroOne Medical Technologies Corporation 2025 Equity Incentive Plan Adopted by the Board of Directors: January 10, 2025 Approved by the Stockholders: February 14, 2025
12/34/56
EX-10.9
from 10-K 2 pages NeuroOne Medical Technologies Corporation Amended and Restated Non-Employee Director Compensation Policy Effective Date: October 1, 2024
12/34/56
EX-10.1
from 8-K 44 pages Certain Identified Information Has Been Excluded From the Exhibit Because It Is Both (I) Not Material and (II) Is of the Type That the Company Treats as Private or Confidential. Double Asterisks Denote Omissions. Amended and Restated Exclusive Development and Distribution Agreement
12/34/56
EX-10.4
from 8-K 3 pages First Amendment to Offer Letter
12/34/56
EX-10.3
from 8-K 3 pages First Amendment to Offer Letter
12/34/56
EX-10.2
from 8-K 3 pages First Amendment to Offer Letter
12/34/56
EX-10.1
from 8-K 3 pages First Amendment to Employment Agreement
12/34/56
EX-10.3
from S-3/A 4 pages NeuroOne Medical Technologies Corporation Attention: Dave Rosa, Chief Executive Officer 7599 Anagram Drive Eden Prairie, Mn 55344 August 2, 2024
12/34/56
EX-10.1
from 10-Q 4 pages First Amendment to Lease Agreement
12/34/56
EX-10.1
from 8-K 28 pages Securities Purchase Agreement
12/34/56
EX-10.2
from 8-K 1 page First Amendment to NeuroOne Medical Technologies Corportaion 2021 Inducement Plan
12/34/56
EX-10.1
from 8-K 11 pages 7599 Anagram Drive Eden Prairie, Minnesota 55344 November 10, 2023
12/34/56